MGC Pharmaceuticals’ acquires MediCaNL to create an ‘in-house research programme’

() () () () Roby Zomer talks to Proactive London’s Katie Pilbeam about acquiring MediCaNL Inc.

MediCaNL Inc is an Israeli company providing specialist services worldwide to the pharmaceutical sector for the development of new medicines.

He explains, rather than pay for a third party consultant each time for their skills and resources, he wanted this resource to be ‘in-house’.

He goes on to add the cost effective attributes of this deal as MediCaNL offers clinical and preclinical trial services as well as assistance with clinical trials in the form of research data from past studies of all Phase I to IV using a variety of treatment methods.